IBDEI2WH ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46262,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46262,1,3,0)
;;=3^Subluxation of Lens,Left Eye
;;^UTILITY(U,$J,358.3,46262,1,4,0)
;;=4^H27.112
;;^UTILITY(U,$J,358.3,46262,2)
;;=^5005370
;;^UTILITY(U,$J,358.3,46263,0)
;;=T85.22XA^^176^2303^27
;;^UTILITY(U,$J,358.3,46263,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46263,1,3,0)
;;=3^Displacement of IOL,Init Encntr
;;^UTILITY(U,$J,358.3,46263,1,4,0)
;;=4^T85.22XA
;;^UTILITY(U,$J,358.3,46263,2)
;;=^5055529
;;^UTILITY(U,$J,358.3,46264,0)
;;=H25.813^^176^2303^6
;;^UTILITY(U,$J,358.3,46264,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46264,1,3,0)
;;=3^Cataract,Combined Nucl/Cortical,Bilateral
;;^UTILITY(U,$J,358.3,46264,1,4,0)
;;=4^H25.813
;;^UTILITY(U,$J,358.3,46264,2)
;;=^5005293
;;^UTILITY(U,$J,358.3,46265,0)
;;=Z48.810^^176^2303^12
;;^UTILITY(U,$J,358.3,46265,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46265,1,3,0)
;;=3^Aftercare Following EYE Surgery
;;^UTILITY(U,$J,358.3,46265,1,4,0)
;;=4^Z48.810
;;^UTILITY(U,$J,358.3,46265,2)
;;=^5063047
;;^UTILITY(U,$J,358.3,46266,0)
;;=H26.109^^176^2303^22
;;^UTILITY(U,$J,358.3,46266,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46266,1,3,0)
;;=3^Retained Lens Fragments in Eye s/p Surgery,Unspec Eye
;;^UTILITY(U,$J,358.3,46266,1,4,0)
;;=4^H26.109
;;^UTILITY(U,$J,358.3,46266,2)
;;=^5133478
;;^UTILITY(U,$J,358.3,46267,0)
;;=H20.00^^176^2304^1
;;^UTILITY(U,$J,358.3,46267,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46267,1,3,0)
;;=3^Iridocyclitis,Acute/Subacute NEC
;;^UTILITY(U,$J,358.3,46267,1,4,0)
;;=4^H20.00
;;^UTILITY(U,$J,358.3,46267,2)
;;=^5005133
;;^UTILITY(U,$J,358.3,46268,0)
;;=H20.051^^176^2304^12
;;^UTILITY(U,$J,358.3,46268,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46268,1,3,0)
;;=3^Hypopyon,Right Eye
;;^UTILITY(U,$J,358.3,46268,1,4,0)
;;=4^H20.051
;;^UTILITY(U,$J,358.3,46268,2)
;;=^5005150
;;^UTILITY(U,$J,358.3,46269,0)
;;=H20.052^^176^2304^13
;;^UTILITY(U,$J,358.3,46269,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46269,1,3,0)
;;=3^Hypopyon,Left Eye
;;^UTILITY(U,$J,358.3,46269,1,4,0)
;;=4^H20.052
;;^UTILITY(U,$J,358.3,46269,2)
;;=^5005151
;;^UTILITY(U,$J,358.3,46270,0)
;;=B00.52^^176^2304^6
;;^UTILITY(U,$J,358.3,46270,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46270,1,3,0)
;;=3^Herpes Viral Keratitis
;;^UTILITY(U,$J,358.3,46270,1,4,0)
;;=4^B00.52
;;^UTILITY(U,$J,358.3,46270,2)
;;=^5000474
;;^UTILITY(U,$J,358.3,46271,0)
;;=B00.51^^176^2304^7
;;^UTILITY(U,$J,358.3,46271,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46271,1,3,0)
;;=3^Herpes Viral Iridocyclitis
;;^UTILITY(U,$J,358.3,46271,1,4,0)
;;=4^B00.51
;;^UTILITY(U,$J,358.3,46271,2)
;;=^5000473
;;^UTILITY(U,$J,358.3,46272,0)
;;=B00.59^^176^2304^8
;;^UTILITY(U,$J,358.3,46272,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46272,1,3,0)
;;=3^Herpes Viral Eye Disease NEC
;;^UTILITY(U,$J,358.3,46272,1,4,0)
;;=4^B00.59
;;^UTILITY(U,$J,358.3,46272,2)
;;=^5000476
;;^UTILITY(U,$J,358.3,46273,0)
;;=B02.33^^176^2304^9
;;^UTILITY(U,$J,358.3,46273,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46273,1,3,0)
;;=3^Herpes Zoster Keratitis
;;^UTILITY(U,$J,358.3,46273,1,4,0)
;;=4^B02.33
;;^UTILITY(U,$J,358.3,46273,2)
;;=^5000496
;;^UTILITY(U,$J,358.3,46274,0)
;;=B02.32^^176^2304^10
;;^UTILITY(U,$J,358.3,46274,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46274,1,3,0)
;;=3^Herpes Zoster Iridocyclitis
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2WH 3801 printed Apr 09, 2024@21:07:27 Page 2
IBDEI2WH ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46262,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,46262,1,3,0)
+4 ;;=3^Subluxation of Lens,Left Eye
+5 ;;^UTILITY(U,$J,358.3,46262,1,4,0)
+6 ;;=4^H27.112
+7 ;;^UTILITY(U,$J,358.3,46262,2)
+8 ;;=^5005370
+9 ;;^UTILITY(U,$J,358.3,46263,0)
+10 ;;=T85.22XA^^176^2303^27
+11 ;;^UTILITY(U,$J,358.3,46263,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,46263,1,3,0)
+14 ;;=3^Displacement of IOL,Init Encntr
+15 ;;^UTILITY(U,$J,358.3,46263,1,4,0)
+16 ;;=4^T85.22XA
+17 ;;^UTILITY(U,$J,358.3,46263,2)
+18 ;;=^5055529
+19 ;;^UTILITY(U,$J,358.3,46264,0)
+20 ;;=H25.813^^176^2303^6
+21 ;;^UTILITY(U,$J,358.3,46264,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,46264,1,3,0)
+24 ;;=3^Cataract,Combined Nucl/Cortical,Bilateral
+25 ;;^UTILITY(U,$J,358.3,46264,1,4,0)
+26 ;;=4^H25.813
+27 ;;^UTILITY(U,$J,358.3,46264,2)
+28 ;;=^5005293
+29 ;;^UTILITY(U,$J,358.3,46265,0)
+30 ;;=Z48.810^^176^2303^12
+31 ;;^UTILITY(U,$J,358.3,46265,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,46265,1,3,0)
+34 ;;=3^Aftercare Following EYE Surgery
+35 ;;^UTILITY(U,$J,358.3,46265,1,4,0)
+36 ;;=4^Z48.810
+37 ;;^UTILITY(U,$J,358.3,46265,2)
+38 ;;=^5063047
+39 ;;^UTILITY(U,$J,358.3,46266,0)
+40 ;;=H26.109^^176^2303^22
+41 ;;^UTILITY(U,$J,358.3,46266,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,46266,1,3,0)
+44 ;;=3^Retained Lens Fragments in Eye s/p Surgery,Unspec Eye
+45 ;;^UTILITY(U,$J,358.3,46266,1,4,0)
+46 ;;=4^H26.109
+47 ;;^UTILITY(U,$J,358.3,46266,2)
+48 ;;=^5133478
+49 ;;^UTILITY(U,$J,358.3,46267,0)
+50 ;;=H20.00^^176^2304^1
+51 ;;^UTILITY(U,$J,358.3,46267,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,46267,1,3,0)
+54 ;;=3^Iridocyclitis,Acute/Subacute NEC
+55 ;;^UTILITY(U,$J,358.3,46267,1,4,0)
+56 ;;=4^H20.00
+57 ;;^UTILITY(U,$J,358.3,46267,2)
+58 ;;=^5005133
+59 ;;^UTILITY(U,$J,358.3,46268,0)
+60 ;;=H20.051^^176^2304^12
+61 ;;^UTILITY(U,$J,358.3,46268,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,46268,1,3,0)
+64 ;;=3^Hypopyon,Right Eye
+65 ;;^UTILITY(U,$J,358.3,46268,1,4,0)
+66 ;;=4^H20.051
+67 ;;^UTILITY(U,$J,358.3,46268,2)
+68 ;;=^5005150
+69 ;;^UTILITY(U,$J,358.3,46269,0)
+70 ;;=H20.052^^176^2304^13
+71 ;;^UTILITY(U,$J,358.3,46269,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,46269,1,3,0)
+74 ;;=3^Hypopyon,Left Eye
+75 ;;^UTILITY(U,$J,358.3,46269,1,4,0)
+76 ;;=4^H20.052
+77 ;;^UTILITY(U,$J,358.3,46269,2)
+78 ;;=^5005151
+79 ;;^UTILITY(U,$J,358.3,46270,0)
+80 ;;=B00.52^^176^2304^6
+81 ;;^UTILITY(U,$J,358.3,46270,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,46270,1,3,0)
+84 ;;=3^Herpes Viral Keratitis
+85 ;;^UTILITY(U,$J,358.3,46270,1,4,0)
+86 ;;=4^B00.52
+87 ;;^UTILITY(U,$J,358.3,46270,2)
+88 ;;=^5000474
+89 ;;^UTILITY(U,$J,358.3,46271,0)
+90 ;;=B00.51^^176^2304^7
+91 ;;^UTILITY(U,$J,358.3,46271,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,46271,1,3,0)
+94 ;;=3^Herpes Viral Iridocyclitis
+95 ;;^UTILITY(U,$J,358.3,46271,1,4,0)
+96 ;;=4^B00.51
+97 ;;^UTILITY(U,$J,358.3,46271,2)
+98 ;;=^5000473
+99 ;;^UTILITY(U,$J,358.3,46272,0)
+100 ;;=B00.59^^176^2304^8
+101 ;;^UTILITY(U,$J,358.3,46272,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,46272,1,3,0)
+104 ;;=3^Herpes Viral Eye Disease NEC
+105 ;;^UTILITY(U,$J,358.3,46272,1,4,0)
+106 ;;=4^B00.59
+107 ;;^UTILITY(U,$J,358.3,46272,2)
+108 ;;=^5000476
+109 ;;^UTILITY(U,$J,358.3,46273,0)
+110 ;;=B02.33^^176^2304^9
+111 ;;^UTILITY(U,$J,358.3,46273,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,46273,1,3,0)
+114 ;;=3^Herpes Zoster Keratitis
+115 ;;^UTILITY(U,$J,358.3,46273,1,4,0)
+116 ;;=4^B02.33
+117 ;;^UTILITY(U,$J,358.3,46273,2)
+118 ;;=^5000496
+119 ;;^UTILITY(U,$J,358.3,46274,0)
+120 ;;=B02.32^^176^2304^10
+121 ;;^UTILITY(U,$J,358.3,46274,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,46274,1,3,0)
+124 ;;=3^Herpes Zoster Iridocyclitis
